R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D
7th TPD & Induced Proximity Summit banner image
Partner Content

7th TPD & Induced Proximity Summit

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D
7th TPD & Induced Proximity Summit banner image
Partner Content

7th TPD & Induced Proximity Summit

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address

R&D
3rd Lipid Nanoparticles Development Summit Europe banner
Partner Content

3rd Lipid Nanoparticles Development Summit Europe

Unlock LNP potential with enhanced clinical translatability at the 3rd Lipid Nanoparticles Development Summit Europe (24-26 September, Berlin, Germany), the leading dedicated LNP f